|
Neurology 2003;60:555-559 © 2003 American Academy of Neurology Variability of total phenytoin serum concentrations within elderly nursing home residentsFrom Experimental & Clinical Pharmacology (Drs. Birnbaum, Leppik, Conway, Lackner, and Graves, and N. Hardie and S. Bowers), Epilepsy Research and Education Program, College of Pharmacy; Department of Neurology (Dr. Leppik), Medical School, University of Minnesota, Minneapolis; and MINCEP Epilepsy Care (Dr. Leppik), Minneapolis, MN. Address correspondence and reprint requests to Dr. Angela Birnbaum, University of Minnesota, Experimental & Clinical Pharmacology, College of Pharmacy, 7-170 WDH, 308 Harvard St. SE, Minneapolis, MN 55455; e-mail: birnb002{at}umn.edu Background: Approximately 6% of all elderly nursing home residents receive phenytoin. Phenytoin concentrations are often measured to guide therapy. Objective: To evaluate the intraresident variability among multiple measurements of total phenytoin serum concentrations in nursing home residents.
Methods: This was an observational study of 56 elderly ( Results: The mean age was 80.1 years (range, 65 to 100 years) and 58.9% were women. The mean daily dose of phenytoin per resident was 4.9 ± 1.5 mg/kg. Total phenytoin concentrations within an elderly nursing home resident varied as much as two- to threefold, even though there was no change in dose. The person with the smallest variability had a minimum concentration of 10.0 µg/mL and a maximum of 10.4 µg/mL. The person with the largest variability had a minimum concentration of 9.7 µg/mL and a maximum of 28.8 µg/mL. Conclusions: There is considerable variability in the total phenytoin concentrations in the elderly nursing home resident and measurement of a single total phenytoin concentration should not be used to guide treatment. This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 years) nursing home residents from 32 nursing homes who had at least 3 phenytoin concentrations measured while on the same dose of phenytoin for at least 4 weeks and who were not taking any interfering concomitant medications. These were a subset of 387 elderly nursing home residents from 112 nursing homes across the United States who had total phenytoin concentration measurements between June 1998 and December 2000. 
